Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.59), versus ($0.69) reported last year. Revenue for the quarter came in at $7.3 million, versus $3.97 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.